X0306
4
2019-02-14
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001715153
Bristol James Arthur
C/O DECIPHERA PHARMACEUTICALS, INC.
500 TOTTEN POND ROAD
WALTHAM
MA
02451
1
0
0
0
Common Stock
2019-02-14
4
M
0
1101
1.89
A
1101
D
Common Stock
2019-02-14
4
S
0
1101
28.0126
D
0
D
Common Stock
2019-02-15
4
M
0
17782
1.89
A
17782
D
Common Stock
2019-02-15
4
S
0
17782
28.0398
D
0
D
Stock Option (Right to Buy)
1.89
2019-02-14
4
M
0
1101
0.00
D
2025-12-17
Common Stock
1101
131190
D
Stock Option (Right to Buy)
1.89
2019-02-15
4
M
0
17782
0.00
D
2025-12-17
Common Stock
17782
113408
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to
$28.04, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera
Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares
sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.00 to $28.06, inclusive. The reporting person undertakes to provide to Deciphera Pharmaceuticals, Inc., any security holder of Deciphera Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This stock option award was issued pursuant to Deciphera Pharmaceuticals, LLC's 2015 Equity Incentive Plan. The option was 100% exercisable
on the date of grant, December 18, 2015.
/s/ Thomas P. Kelly, Attorney-in-Fact
2019-02-19